(Q30563725)

24 June 2017

title

Protease-activated receptor 2 signaling upregulates angiogenic growth factors in renal cell carcinoma (English)

1 reference

24 June 2017

1 reference

6

Robert L Vessella

1 reference

24 June 2017

5

Lawrence D True

1 reference

24 June 2017

Xiaotun Zhang

1

1 reference

24 June 2017

Wenbin Wang

series ordinal

2

1 reference

24 June 2017

Gregory J Mize

series ordinal

3

1 reference

24 June 2017

Thomas K Takayama

series ordinal

4

1 reference

24 June 2017

publication date

31 August 2012

1 reference

Experimental and Molecular Pathology

24 June 2017

published in

1 reference

24 June 2017

volume

94

1 reference

24 June 2017

issue

1

1 reference

24 June 2017

page(s)

91-97

1 reference

IL-6 as an intracrine growth factor for renal carcinoma cell lines

24 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Interleukin-6 in bone metastasis and cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

VHL and HIF signalling in renal cell carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Tumorigenesis and the angiogenic switch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Molecular mechanisms and clinical applications of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Thrombin signalling and protease-activated receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Aberrant Expression and Activation of the Thrombin Receptor Protease-Activated Receptor-1 Induces Cell Proliferation and Motility in Human Colon Cancer Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

What Is the Evidence That Tumors Are Angiogenesis Dependent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

The serine proteinase thrombin promotes migration of human renal carcinoma cells by a PKA-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Protease-activated receptors in cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Chemokines as therapeutic targets in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Tissue factor and cell signalling in cancer progression and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of renal carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.08.005

10.1016/J.YEXMP.2012.08.005

7 January 2021

Identifiers

DOI

1 reference

24 June 2017

1 reference